Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.
2.

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.

Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N.

Cancer. 1996 Oct 1;78(7):1403-16.

PMID:
8839545
3.

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.

Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A.

Cancer. 2001 May 15;91(10):1862-9.

PMID:
11346867
5.
6.
7.
8.
9.
10.

Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.

Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.

Cancer. 2006 Jan 1;106(1):42-50.

12.

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

PMID:
21935747
13.

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.

Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA.

Breast Cancer Res Treat. 2000 Aug;62(3):197-210.

PMID:
11072784
14.

Factors predicting in-breast tumor recurrence after breast-conserving surgery.

Mechera R, Viehl CT, Oertli D.

Breast Cancer Res Treat. 2009 Jul;116(1):171-7. doi: 10.1007/s10549-008-0187-y. Epub 2008 Sep 25.

PMID:
18815880
15.

Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.

Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK.

Cancer. 2002 Nov 15;95(10):2059-67.

16.

[Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].

Aulmann S, Penzel R, Schirmacher P, Sinn HP.

Verh Dtsch Ges Pathol. 2007;91:208-13. German.

PMID:
18314616
17.

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.

Buerger H, Simon R, Schäfer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Böcker W.

Mol Pathol. 2000 Jun;53(3):118-21.

18.

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.

Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A.

J Clin Oncol. 2005 Aug 20;23(24):5534-41.

PMID:
16110014
19.

Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.

Ringberg A, Palmer B, Linell F, Rychterova V, Ljungberg O.

Eur J Surg Oncol. 1991 Feb;17(1):20-9.

PMID:
1847343
20.

Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group.

Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA.

Am J Surg Pathol. 1993 Jan;17(1):14-21.

PMID:
8383466

Supplemental Content

Support Center